← SynDRA
BOS-172722
SynDRA canonical compound SYN0038642 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | TTK |
|---|
| Mechanism of action | monopolar spindle 1 kinase inhibitor |
|---|
All known targets
- TTK
- LRRK2
- MAPK10
- MAPK8
- MAPK9
Mechanisms of action (all sources)
- LRRK2 INHIBITOR
- MAPK10 INHIBITOR
- MAPK8 INHIBITOR
- MAPK9 INHIBITOR
- TTK INHIBITOR
- monopolar spindle 1 kinase inhibitor
Cross-references
Synonyms
- Bos172722
- BOS172722
- SGWLRDAOCLITOM-UHFFFAOYSA-N
- SCHEMBL15515080
- CHEMBL3924132
- BDBM241338
- US9409907, 182
- BOS 172722
- RefChem:121064
- TTK Inhibitor BOS172722
- Mps1 Inhibitor BOS172722
- Monopolar Spindle 1 Inhibitor BOS172722
- MFCD31692374
- orb1308530
- SCHEMBL29548143
- GTPL12706
- TQP0933
- GLXC-21162
- EX-A4893
- NSC809694
- s8911
- AKOS040741446
- BOS172722?
- NSC-809694
- compound 36 [PMID: 30199249]
- BB167286
- DA-71681
- MS-28074
- HY-112162
- CS-0043580
- G16376
- T14765
- FMW
- 2K4CP8SA45
- Bos172722 DI P-toluenesulfonate
- BOS-172722 ditosylate
Look up BOS-172722 in the interactive SynDRA portal →